The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2024Determining Optimal Cognitive Measures and Clinical Trial Endpoints in Lewy Body Disorders
Study Rationale: People with Lewy body disorders, including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), often experience cognitive impairment that can impact function, independence...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2024Alterations in DNA Repair Mechanisms in Parkinson’s Disease Neurons and their Correlation with Clinical Variables
Study Rationale: Preserving the fidelity of genetic information is essential for life. Consequently, all organisms have developed efficient systems for repairing DNA damage. One of the consequences of...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024Assessing the Safety and Efficacy of a Novel Enzyme Inhibitor in Reducing Neuroinflammation and Enhancing Neuroprotection in Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) is characterized by neuroinflammation and the loss of dopamine neurons. Recently, epoxy-fatty acids have been shown to be neuroprotective in preclinical...
-
iPSC Phenotyping Environmental Exposure Program, 2024Establishing a Proof-of-concept, Automated Platform for Studying the Interactions of Genetic and Environment-based Toxicity in Human Cell Models of Parkinson’s Disease
Study Rationale: Many studies of Parkinson’s disease (PD) focus on investigating the disease’s genetic component. Yet only about 22% of PD diagnoses carry a genetic association. Increasing evidence...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024Evaluating the Role of CK1d Inhibition in Sleep Dysregulation and Alpha-synuclein Pathology in Preclinical Models of Parkinson’s Disease
Study Rationale: Disrupted sleep is an early sign of Parkinson’s disease (PD) that worsens as the disease progresses. Chronic symptoms of PD include alternations in sleep patterns and changes in the...
-
iPSC Phenotyping Environmental Exposure Program, 2024Using Stem-cell Derived Brain-chip Technologies to Evaluate the Contributions of Environmental Toxins to Parkinson’s Disease
Study Rationale: Chronic exposure to environmental contaminants is believed to play an important role in the initiation of Parkinson’s disease (PD). With an estimated 40,000 to 60,000 chemicals that...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.